These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2854686)

  • 1. [Presence of anti-CMV antibodies in the sera of blood donors].
    Kazimierska E; Górski J
    Wiad Lek; 1988 Oct; 41(19):1271-3. PubMed ID: 2854686
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
    Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood donor selection in providing anticytomegalovirus-negative blood components].
    Koerner K; Freudenberg J; Kubanek B
    Dtsch Med Wochenschr; 1989 Feb; 114(6):203-7. PubMed ID: 2537170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of cytomegalovirus antibody titers in sera of volunteer blood donors by use of complement fixation and two immunoenzymatic tests.
    Dzierzanowska D; Kołodziejczyk J; Lourie I
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):397-402. PubMed ID: 3026277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of cytomegalovirus in blood donation].
    Albert S; Kühnl P; Sibrowski W; Seidl S; Doerr HW
    Infusionstherapie; 1990 Feb; 17(1):48-56. PubMed ID: 2159951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytomegalovirus seronegative blood donors: studies of the rate of seroconversions in relation to age structure].
    Wangerin R; Diekamp U
    Beitr Infusionsther; 1988; 21():205-10. PubMed ID: 2462977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevalence of antibodies against CMV in Grenada].
    Rojo MD; García MV; Oyonarte S; Mendoza J; Carazo C; Fernández-Montoya A
    Sangre (Barc); 1992 Aug; 37(4):293-5. PubMed ID: 1325073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rational microanalysis technic in the detection of antibodies to HTLV-III, CMV and EBV with indirect immunofluorescence].
    Stöcker W; Geusendam G; Schmitz H; Mohr H; Berndt H
    Beitr Infusionther Klin Ernahr; 1986; 15():51-7. PubMed ID: 3019301
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
    Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
    Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
    Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
    J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cytomegalovirus infection in patients with Guillain-Barré syndrome.
    Steininger C; Seiser A; Gueler N; Puchhammer-Stöckl E; Aberle SW; Stanek G; Popow-Kraupp T
    J Neuroimmunol; 2007 Feb; 183(1-2):214-9. PubMed ID: 17184845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The duration of Cytomegalovirus complement fixation antibodies in patients with CMV hepatitis].
    Kaynar V; Durusu Z
    Mikrobiyol Bul; 1981 Jan; 15(1):31-4. PubMed ID: 6300616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection in Penang: a serological survey.
    Madhavan HN; Ong KH; Anuar K
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):168-71. PubMed ID: 3024324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytomegalovirus antibodies in patients and personnel of a hemodialysis unit].
    Szepietowski T; Adamiec R; Imbs D
    Pol Arch Med Wewn; 1983 Sep; 70(3):101-10. PubMed ID: 6318193
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus mononucleosis--a report of 70 cases in a community hospital.
    Porath A; Schlaeffer F; Sarov I; Keynan A
    Isr J Med Sci; 1987 Apr; 23(4):268-73. PubMed ID: 3040620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cytomegalovirus testing on blood collection facilities.
    Silvergleid AJ; Kott TJ
    Vox Sang; 1983; 44(2):102-5. PubMed ID: 6299011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against cytomegalovirus in blood donors ].
    Medarde Agustín A; Eguaras Aldave J
    Sangre (Barc); 1982; 27(2):190-7. PubMed ID: 6289480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of Cytomegalovirus antibodies in the region of Valencia (author's transl)].
    Sanchis-Bayarri Vaillant V; Donderis Torrens S
    Sangre (Barc); 1975; 20(3):323-6. PubMed ID: 173029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.